Last reviewed · How we verify
Medicinal cannabis in combination with oxycodon — Competitive Intelligence Brief
marketed
Small molecule
Live · refreshed every 30 min
Target snapshot
Medicinal cannabis in combination with oxycodon (Medicinal cannabis in combination with oxycodon) — Leiden University Medical Center.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Medicinal cannabis in combination with oxycodon TARGET | Medicinal cannabis in combination with oxycodon | Leiden University Medical Center | marketed |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Medicinal cannabis in combination with oxycodon CI watch — RSS
- Medicinal cannabis in combination with oxycodon CI watch — Atom
- Medicinal cannabis in combination with oxycodon CI watch — JSON
- Medicinal cannabis in combination with oxycodon alone — RSS
Cite this brief
Drug Landscape (2026). Medicinal cannabis in combination with oxycodon — Competitive Intelligence Brief. https://druglandscape.com/ci/medicinal-cannabis-in-combination-with-oxycodon. Accessed 2026-05-16.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab